Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody

The Wilms tumor 1 (WT1) oncoprotein is an intracellular, oncogenic transcription factor that is overexpressed in a wide range of leukemias and solid cancers. RMFPNAPYL (RMF), a WT1-derived CD8(+) T cell human leukocyte antigen (HLA)–A0201 epitope, is a validated target for T cell–based immunotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dao, Tao, Yan, Su, Veomett, Nicholas, Pankov, Dmitry, Zhou, Liang, Korontsvit, Tatyana, Scott, Andrew, Whitten, Joseph, Maslak, Peter, Casey, Emily, Tan, Taochao, Liu, Hong, Zakhaleva, Victoria, Curcio, Michael, Doubrovina, Ekaterina, O’Reilly, Richard J., Liu, Cheng, Scheinberg, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963696/
https://ncbi.nlm.nih.gov/pubmed/23486779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3005661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados